COLORADO (KOAA) — Colorado Governor Jared Polis has activated Phase 3 of the state's Drought Response Plan and issued a statewide Drought Emergency declaration. The declaration and plan activation are ...
DENVER — Gov. Jared Polis on Thursday declared a statewide drought emergency as he activated Phase 3 of the state’s drought response plan. Colorado’s record‑low snowpack and the extreme warmth have ...
b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.
Patient reported outcomes (PRO) during and after multimodal treatment for resectable esophageal adenocarcinoma in the prospective, randomized, controlled, multicenter phase III ESOPEC trial.
Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...
SAO PAULO, May 19 (Reuters) - Brazil's Finance Ministry on Tuesday released a preliminary proposal for phased sectoral coverage of the country's regulated carbon market, outlining which industries ...
When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...
Copyright: © 2026 The Author(s). Published by Elsevier Ltd. Between Jan 5, 2023, and April 8, 2024, 381 patients were randomly assigned to the relacorilant ...
Subcutaneous teprotumumab every 2 weeks for 24 weeks produced robust proptosis responses (≥2 mm) and magnitude of reduction comparable to historical IV benchmarks in active TED. Clinical benefit ...
Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...
An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday; however, the latter firm's shares fell because the clinical trial did not ...
Following positive results from a Phase 3 clinical study, United Therapeutics plans to submit an application to the U.S. Food and Drug Administration (FDA) by the second half of 2026 seeking approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results